Rare Disease Innovation Hub Established by FDA

FDA has established a new Rare Disease Innovation Hub (the Hub) to leverage cross-agency expertise and spur the development of treatments for rare diseases, CDER Director Patrizia Cavazzoni and CBER Director Peter Marks announced recently.
Source: Drug Industry Daily